Ephedra Safety Studies Urged By Burton In Letter To FDA
This article was originally published in The Tan Sheet
Executive Summary
FDA should "support clinical trials that will examine scientifically the safety of ephedra when properly used," Rep. Dan Burton (R-Ind.) states in a May 19 letter to the agency